Digital Health
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients.
Also: MGH and MIT create new tool for organizations to calculate benefits of onsite COVID-19 testing and Scanwell teams up with BD for a home coronavirus test.
The University Health Network study is being conducted in collaboration with the tech giant, and will enroll roughly 200 patients for three months of active monitoring with a two-year follow-up.
Also: The Consumer Technology Association releases industry standards focused on health AI trust; new updates in the home COVID-19 testing market.
The pandemic has created the need for more integrated digital tools, says Xealth CEO Mike McSherry.
Community by Current Health is now enrolling participants in a COVID-19 study that uses its FDA-cleared remote monitoring system.
Also: docdok.health rolling out COVID-19 vaccination study app; IBM Watson Health partners with Humana.
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.
The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.